진료과/의료진
환자 중심의 고품격 진료
- HOME
- 진료과/클리닉/센터
- 특성화센터
- 암병원(3F)
- 의료진
의료진 찾기
아래 검색을 통해 정확하고 빠르게 의료진을 검색할 수 있습니다.
특성화센터 안내 [문의전화] 1577-9966
특성화센터를 안내해 드립니다. 클릭 시 해당 특성화센터의 자세한 사항을 보실 수 있습니다.
암병원(3F)
-
[SCI]
C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition,
Tae-Min Cho, Ji Young Kima, Yoon-Jae Kim, Daeil Sung, Eunhye Oh, Seojin, Jang, Lee Farrand, Van-Hai Hoang, Cong-Truong Nguyen, Jihyae Ann, Jeewoo Lee, and Jae Hong Seo, / C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition, / 447:141-153, 2019 (IF 6.491) / 201907 -
[SCI]
Investigation of B, C-ring truncated deguelin derivatives as heat shock protein 90(HSP90) inhibitor for use as anti-breast cancer agents
Kim HS, Hoang VH, Hong M, Kim KC, Ann J, Nguyen CT, Seo JH, Choi H, Kim JY, Kim KW, Byun WS, Lee S, Lee S, Suh YG, Chen J, Park HJ, Cho TM, Kim JY, Seo JH, Lee J / Investigation of B, C-ring truncated deguelin derivatives as heat shock protein 90(HSP90) inhibitor for use as anti-breast cancer agents / 27(7):1370-1381, 2019 (IF 2.93) r / 201907 -
[SCI]
Pulmonary function is implicated in the prognosis non-small cell lung cancer but not in extended disease small cell lung cancer.
Lee SY, Choi YJ, Seo JH, Lee SY, Kim JS, Kang EJ. / Pulmonary function is implicated in the prognosis non-small cell lung cancer but not in extended disease small cell lung cancer. / 2019;11(11):4562-4572. / 201907 -
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
/ Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) / 2019;121:985-990. / 201907 -
Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response.
/ Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response. / 2019. doi: 10.1158/1541-7786.MCR-19-0453 / 201907
(우) 08308. 서울시 구로구 구로동로 148(구로동) 대표번호 : 02-2626-1114 진료예약센터 : 1577-9966
Copyrightⓒ 2010 by Korea University Guro Hospital All Rights Reserved.
